Compare · RVTY vs SEER
RVTY vs SEER
Side-by-side comparison of Revvity Inc. (RVTY) and Seer Inc. (SEER): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RVTY and SEER operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- RVTY is the larger of the two at $12.40B, about 103.9x SEER ($119.3M).
- Over the past year, RVTY is up 12.7% and SEER is up 2.3% - RVTY leads by 10.3 points.
- SEER has been more active in the news (20 items in the past 4 weeks vs 5 for RVTY).
- RVTY has more recent analyst coverage (20 ratings vs 8 for SEER).
- Company
- Revvity Inc.
- Seer Inc.
- Price
- $111.03-1.10%
- $2.18+0.00%
- Market cap
- $12.40B
- $119.3M
- 1M return
- +9.49%
- +28.24%
- 1Y return
- +12.66%
- +2.35%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 5
- 20
- Recent ratings
- 20
- 8
Seer Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Latest RVTY
- Revvity to Hold Earnings Call on Tuesday, August 4, 2026
- Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration
- Bernstein resumed coverage on Revvity with a new price target
- SEC Form 11-K filed by Revvity Inc.
- Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
- Vice President and CAO Gonzales Anita covered exercise/tax liability with 33 shares, decreasing direct ownership by 0.45% to 7,286 units (SEC Form 4) to cover taxes
- Wolfe Research resumed coverage on Revvity
- SEC Form SD filed by Revvity Inc.
- SEC Form 10-Q filed by Revvity Inc.
- Director Klobuchar Michael A was granted 2,280 shares, increasing direct ownership by 45% to 7,368 units (SEC Form 4)
Latest SEER
- Director Nishar Dipchand sold $23,265 worth of shares (10,660 units at $2.18) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 59,044 units (SEC Form 4) to cover withholding tax
- SEC Form DFAN14A filed by Seer Inc.
- The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of History
- SEC Form 144 filed by Seer Inc.
- SEC Form DEFA14A filed by Seer Inc.
- SEC Form DEFA14A filed by Seer Inc.
- Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
- SEC Form DEFA14A filed by Seer Inc.
- SEC Form DFAN14A filed by Seer Inc.
- The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.